Lovastatin Tablet
Product Images NDC 50090-3268

3 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 50090-3268). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Image 1
Chemical structure diagram of lovastatin, showing its molecular configuration with labeled functional groups and stereochemistry.*
FDA Label Image

Image 2

Image 2
A line graph titled 'Acute Major Coronary Events (Primary Endpoint)' showing the proportion of participants without event over years of follow-up. Two lines represent Lovastatin and Placebo groups, with Lovastatin showing a higher event-free proportion and a noted 37% risk reduction (p < 0.001) compared to Placebo over approximately six years.*
FDA Label Image

Label Image (Lbl500903216)

Label Image (Lbl500903216)
Lovastatin 40 mg tablet label from A-S Medication Solutions, with storage instructions to keep the tablets at 68 to 77 degrees Fahrenheit and protect from light. The label indicates the bottle contains 30 tablets and shows the manufacturer location as Zagreb, Croatia.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.